Rocky Mountain Cancer Centers SC-2 — Denver, Colorado

Rocky Mountain Cancer Centers SC-2 is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers SC-2 has participated in 1 clinical trials.

Therapeutic areas: Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin, Well-differentiated Non-functional NET of Pancreatic Origin.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers SC-2?

Rocky Mountain Cancer Centers SC-2 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers SC-2 conducted?

Rocky Mountain Cancer Centers SC-2 has 1 clinical trials on record. Their work covers Well-differentiated Non-functional NET of Thoracic Origin, Well-differentiated Non-functional NET of Gastrointestinal Origin, Well-differentiated Non-functional NET of Pancreatic Origin.

Is Rocky Mountain Cancer Centers SC-2 accredited by Crixeo Health?

Rocky Mountain Cancer Centers SC-2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers SC-2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.